PTAFR Antibody (C-term) Blocking peptide
€363.00
In stock
SKU
AC-BP13382b
Background:
PTAFR shows structural characteristics of the rhodopsin(MIM 180380) gene family and binds platelet-activating factor(PAF). PAF is a phospholipid(1-0-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine) that has beenimplicated as a mediator in diverse pathologic processes, such asallergy, asthma, septic shock, arterial thrombosis, andinflammatory processes.
Other Names:
Platelet-activating factor receptor, PAF-R, PAFr, PTAFR, PAFR
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13382b was selected from the C-term region of PTAFR. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: PTAFR
Gene ID: 5724
Primary Accession: P25105
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
PTAFR shows structural characteristics of the rhodopsin(MIM 180380) gene family and binds platelet-activating factor(PAF). PAF is a phospholipid(1-0-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine) that has beenimplicated as a mediator in diverse pathologic processes, such asallergy, asthma, septic shock, arterial thrombosis, andinflammatory processes.
Other Names:
Platelet-activating factor receptor, PAF-R, PAFr, PTAFR, PAFR
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13382b was selected from the C-term region of PTAFR. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: PTAFR
Gene ID: 5724
Primary Accession: P25105
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review